A Focus on VEGF TKIs

Experts discuss the optimal use of VEGF-targeted tyrosine kinase inhibitors for patients with GI malignancies in this this podcast series that includes downloadable summary slidesets.

Share

Supporters

Supported by an educational grant from

Bayer Healthcare Pharma